June 06, 2025
Article
Adding Zyprexa to ondansetron cut nausea and vomiting safely in abdominal/pelvic radiation with low-emetogenic capecitabine.
June 05, 2025
Columvi plus chemo had enhanced survival outcomes vs Rituxan plus chemo in patients with relapsed/refractory diffuse large B-cell lymphoma.
February 21, 2025
For some patients with bladder cancer, neoadjuvant chemotherapy plus bladder-saving concurrent chemoradiation therapy was effective in the long term.
February 16, 2025
Patients with intermediate-risk prostate cancer had a 15-year prostate cancer–specific survival rate of 91% with EBRT, with or without short-term ADT.
This Wasn't the Plan: The Truth
Living With Intention After a Cancer Diagnosis
June Lung Cancer Highlights: Top 5 Updates Patients Should Know
Could Shedding a Few Pounds Prevent a Breast Cancer Recurrence?